To get the context of this article, I suggest you read about Biederman first: http://1boringoldman.com/index.php/2...enny%E2%80%A6/

Claudia M. Gold, M.D., talks about three-year-old Anna who was the victim of trauma before being adopted. Anna's adoptive parents came to see Dr. Gold because of Anna's almost daily severe explosive tantrums.

Dr. Gold was aware of the work of psychiatrist Bruce Perry. His model of intervention is based on knowledge of brain development and is termed the Neurosequential Model of Therapeutics.

How Dr. Gold helped Anna's adoptive parents to reach her is compelling. Gold concludes by stating:

Yet it is just the discipline of infant mental health, as exemplified by the work of Dr. Perry and others I have been exposed to over the past year in the Infant -Parent Mental Health Post-Graduate Certificate Program, that offers the answer to the second question: what is an alternative path to that offered by Biederman and colleagues? That same morning of the blog reading and this visit, I had been communicating with colleagues about developing a new program that integrates care among obstetricians, pediatricians and psychiatrists to address perinatal emotional complications. It has been well established that explosive behavior problems in children are often associated with postpartum depression. It is this kind of preventive work that offers a meaningful alternative approach.

Now that it has, I believe, been clearly established that this explosion of bipolar disorder diagnoses and antipsychotic use in young children was the wrong path, we need to move on. We need to fully invest in making the changes necessary to out health care system to enable us to go down a different path towards meaningful help for these struggling families and children. http://www.psychologytoday.com/blog/...young-children

[splitimage]

Thanks for posting these links Byzantine.

I am so opposed to prescribing antipsychotics to young children. The modern A-typicals all have hormonal side effects that I would not like to see inflicted on developing children. These are serious heavy duty drugs with potentially major side effects, with increased risks the longer you're on them. I reluctantly take an anti-psychotic because it seems to be a critical adjunct to my anti-D treatment, but I'm fully informed of the benefits and the risks and I'm making an informed choice to take it.

It seems to me like antipsychotics are being prescribed more and more for off - label uses and to populations where no research has been conducted.

I don't have kids, so I can't really judge any parent for the choices they make for their children, but I'd always go for a behavioural intervention before drugs.

splitimage

There are many players who inappropriately influence the medications consumers take: http://www.naturalnews.com/corruption.html

In my view, consumers must be proactive in stating their displeasure with being the guinea pigs for the greedy and corrupt. Some people and organizations that need to know it is long past time to put some integrity back into pharmaceuticals:

I just emailed the law firm ( contact@fuerstlaw.com) representing seven large pharmaceutical manufacturers that filed a citizen petition on July 5, 2011, with the U.S. Food and Drug Administration (FDA) asking the Commissioner to “clarify FDA regulations and policies with respect to manufacturer dissemination of information related to new uses of marketed drugs and medical devices.”

Contact FDA: http://www.fda.gov/AboutFDA/ContactFDA/default.htm I included the Corruption news, articles and information from the Natural News site: http://www.naturalnews.com/corruption.html

To send customer feedback to the Agency for Healthcare Research and Quality Guidelines, a part of the U.S. Department of Health and Human Services: https://info.ahrq.gov.

To provide President Obama with feedback: http://www.whitehouse.gov/contact

Contacting state congressional delegations: http://en.wikipedia.org/wiki/Categor...tions_by_state

The Subcommittee on Agriculture, Rural Development, Food and Drug Administration, and Related Agencies is chaired by Senator Herb Kohl (Chairman) (WI)

United States House Appropriations Subcommittee on Agriculture, Rural Development, Food and Drug Administration, and Related Agencies is chaired by Jack Kingston, Georgia, Chairman.

For feedback to the National Institutes of Health: IH-Listens@mail.nih.gov

For feedback to the National Institute of Mental Health: nimhinfo@nih.gov

Feedback may be sent to the World Health Organization here: http://www.who.int/suggestions/en/index.html